GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

$ 1799




Generic drugs are low-cost versions of off-patent innovator drugs with the same dosage, effects, use, route of administration, etc. In the GCC region, the demand for generic drugs has been rising due to the cost-containment measure by the governments stimulated by the unsustainably high spending on healthcare in the region. A large expatriate and low-income population also acts as a driver for the market growth. According to IMARC Group’s latest report titled “GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the generic drugs market in the GCC reached a value of nearly US$ 1,783 Million in 2017, exhibiting a CAGR of 15% during 2010-2017.

One of the major factors that is expected to boost the market is the mounting pharmaceutical manufacturing capacity in the region boosted by the plans for regional integration and a greater emphasis on drugs produced within the GCC. The efforts to reduce dependence on imported drugs will further stimulate domestic manufacturing of drugs, particularly generics. Moreover, the government of Saudi Arabia, Oman and UAE have started campaigns aimed at boosting awareness towards the substitution of branded drugs by generics. However, the preference for branded drugs supported by a significant affluent population and the demand for sophisticated pharmaceuticals can hamper the market growth. Overall, the market is expected to continue its growth, reaching a value of more than US$ XXXX Million by 2023.

The report has segmented the GCC generic drugs market on the basis of countries. Currently, Saudi Arabia represents the largest market in the region, accounting for more than a half of the total market share. This can be attributed to the rapid economic development and the subsequent rise in the cases of lifestyles diseases in the country. The lenient data exclusivity laws in the country have also boosted the market. The report has further analysed the competitive landscape of the market and provides the profiles of the key players operating in it. Some of the key players include Hospira (Pfizer Inc.), Fresenius Kabi Ag, Hikma Pharmaceuticals PLC, Sandoz (Novartis), Sagent Pharmaceuticals, Inc., Sanofi and Baxter International Inc..

GCC Generic Drug Market Report

This report provides a deep insight into the GCC generic drug industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a generic drugs manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the GCC generic drugs industry in any manner.

Key Questions Answered in This Report:

  • How has the GCC generic drugs market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the GCC generic drugs industry?
  • What are the price trends of generic drugs?
  • What are the various stages in the value chain of the GCC generic drugs industry?
  • What are the key driving factors and challenges in the GCC generic drugs industry?
  • What is the structure of the GCC generic drugs industry and who are the key players?
  • What is the degree of competition in the GCC generic drugs industry?
  • What are the profit margins in the GCC generic drugs industry?
  • What are the key requirements for setting up a generic drugs manufacturing plant?
  • How are generic drugs manufactured?
  • What are the various unit operations involved in a generic drugs manufacturing plant?
  • What is the total size of land required for setting up a generic drugs manufacturing plant?
  • What are the machinery requirements for setting up a generic drugs manufacturing plant?
  • What are the raw material requirements for setting up a generic drugs manufacturing plant?
  • What are the packaging requirements for generic drugs?
  • What are the transportation requirements for generic drugs?
  • What are the utility requirements for setting up a generic drugs manufacturing plant?
  • What are the manpower requirements for setting up a generic drugs manufacturing plant?
  • What are the infrastructure costs for setting up a generic drugs manufacturing plant?
  • What are the capital costs for setting up a generic drugs manufacturing plant?
  • What are the operating costs for setting up a generic drugs manufacturing plant?
  • What will be the income and expenditures for a generic drugs manufacturing plant?
  • What is the time required to break-even?

1   Preface
2   Scope and Methodology

   2.1   Objectives of the study
   2.2   Stakeholders
   2.3   Data Sources
        2.3.1 Primary Sources
        2.3.2 Secondary Sources
   2.4    Market Estimation
        2.4.1 Bottom-Up Approach
        2.4.2 Top-Down Approach
   2.5   Forecasting Methodology
3    Executive Summary
4    Introduction

   4.1    Overview
   4.2    Key Industry Trends
5    Global Generic Drug Industry
   5.1    Market Overview
   5.2    Market Performance
   5.3    Market Breakup by Region
   5.4    Market Breakup by Drug Delivery
   5.5    Market Forecast
6    GCC Generic Drug Industry 
   6.1    Market Overview
   6.2    Market Performance
   6.3    Market Breakup by Region
   6.4    Market Forecast
   6.5   SWOT Analysis
        6.5.1    Strengths
        6.5.2    Weaknesses
        6.5.3    Opportunities
        6.5.4    Threats 
   6.6    Value Chain Analysis
        6.6.1  Overview
        6.6.2  Research and Development
        6.6.3  Raw Material Procurement
        6.6.4  Manufacturing
        6.6.5  Marketing
        6.6.6  Distribution
    6.7   Porter’s Five Forces Analysis
        6.7.1    Overview
        6.7.2    Bargaining Power of Buyers
        6.7.3    Bargaining Power of Suppliers
        6.7.4    Degree of Competition
        6.7.5    Threat of New Entrants
        6.7.6    Threat of Substitutes
    6.8    Key Success and Risk Factors for Manufacturers
7   Performance of Key Regions
    7.1    Saudi Arabia 
        7.1.1     Market Performance
        7.1.2     Market Forecast
        7.1.3     Key Players
        7.1.4     Regulatory Process for Generics Drug Industry in Saudi Arabia
    7.2     UAE
        7.2.1    Market Performance
        7.2.2    Market Forecast
        7.2.3    Key Players
        7.2.4    Regulatory Process for Generics Drug Industry in UAE  
    7.3     Kuwait
        7.3.1    Market Performance
        7.3.2    Market Forecast
        7.3.3    Regulatory Process for Generics Drug Industry in Kuwait     
    7.4    Qatar
        7.4.1    Market Performance
        7.4.2    Market Forecast
        7.4.3    Regulatory Process for Generics Drug Industry in Qatar
    7.5   Bahrain
        7.5.1    Market Performance
        7.5.2    Market Forecast
        7.5.3    Regulatory Process for Generics Drug Industry in Bahrain
    7.6   Oman
        7.6.1    Market Performance
        7.6.2    Market Forecast
        7.6.3    Regulatory Process for Generics Drug Industry in Oman
8   Competitive Landscape
    8.1 Competitive Structure
    8.2 Market Share of Key Players
9 Generic Drug Manufacturing Process
    9.1 Product Overview
    9.2 Detailed Process Flow 
    9.3 Various Types of Unit Operations Involved
    9.4 Mass Balance and Raw Material Requirements
10 Project Details, Requirements and Costs Involved
    10.1 Land Requirements and Expenditures
    10.2 Construction Requirements and Expenditures
    10.3 Plant Machinery
    10.4 Machinery Pictures
    10.5 Raw Material Requirements and Expenditures
    10.6 Packaging Requirements and Expenditures
    10.7 Transportation Requirements and Expenditures
    10.8 Utility Requirements and Expenditures
    10.9 Manpower Requirements and Expenditures
    10.10 Other Capital Investments
11 Loans and Financial Assistance
12 Project Economics

    12.1 Capital Cost of the Project
    12.2 Techno-Economic Parameters
    12.3 Product Pricing and Margins across Various Levels of the Supply Chain
    12.4 Taxation and Depreciation
    12.5 Income Projections
    12.6 Expenditure Projections
    12.7 Financial Analysis
    12.8 Profit Analysis
13 Key Player Profiles


List of Figures

Figure 1: Global: Generic Drug Market: Key Market Drivers and Challenges
Figure 2: Global: Generic Drug Market: Sales Value Trends (in Billion US$), 2010 – 2017
Figure 3: Global: Generic Drug Market: Breakup by Region (in %), 2017
Figure 4: Global: Generic Drug Market Forecast: Sales Value Trends (in Billion US$), 2018 – 2023
Figure 5:  GCC: Generic Drug Market: Value Trends (in Million US$), 2010 – 2017
Figure 6: GCC: Generic Drug Market: Breakup by Region (in %), 2017
Figure 7: GCC: Generic Drug Market Forecast: Value Trends (in Million US$), 2018-2023
Figure 8: GCC: Generic Drug Industry: SWOT Analysis
Figure 9: GCC: Generic Drug Industry: Value Chain Analysis
Figure 10: GCC: Generic Drug Industry: Porter’s Five Forces Analysis
Figure 11: Saudi Arabia: Generic Drug Market: Sales Value Trends (in Million US$), 2010-2017
Figure 12: Saudi Arabia: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2018-2023
Figure 13: Saudi Arabia: Generic Drug Market: Breakup by Key Players (in %), 2017
Figure 14: UAE: Generic Drug Market: Sales Value Trends (in Million US$), 2010-2017
Figure 15: UAE: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2018-2023
Figure 16: UAE: Generic Drug Market: Breakup by Key Players (in %), 2017
Figure 17: Kuwait: Generic Drug Market: Sales Value Trends (in Million US$), 2010-2017
Figure 18: Kuwait: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2018-2023
Figure 19: Qatar: Generic Drug Market: Sales Value Trends (in Million US$), 2010-2017
Figure 20: Qatar: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2018-2023
Figure 21: Bahrain: Generic Drug Market: Sales Value Trends (in Million US$), 2010-2017
Figure 22: Bahrain: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2018-2023
Figure 23: Oman: Generic Drug Market: Sales Value Trends (in Million US$), 2010-2017
Figure 24: Oman: Generic Drug Market Forecast: Sales Value Trends (in Million US$), 2018-2023
Figure 25: Generic Drug Manufacturing Plant: Detailed Process Flow
Figure 26: Generic Drug Manufacturing Process: Conversion Rate of Products
Figure 27: Generic Drug Manufacturing Plant: Breakup of Capital Costs (in %)
Figure 28: Generic Drug Industry: Profit Margins at Various Levels of the Supply Chain
Figure 29: Generic Drug Production: Manufacturing Cost Breakup (in %)
Figure 30: Generic Drug Production: Price Structure Analysis 


List of Tables

Table 1: Global: Generic Drug Market: Key Industry Highlights, 2017 and 2023
Table 2: GCC: Generic Drug Market: Key Industry Highlights, 2017 and 2023
Table 3: GCC: Generic Drug Market Forecast: Breakup by Region, 2018-2023
Table 4: Generic Drug Manufacturing Plant: Costs Related to Land and Site Development (in US$)
Table 5: Generic Drug Manufacturing Plant: Costs Related to Civil Works (in US$)
Table 6: Generic Drug Manufacturing Plant: Costs Related to Machinery (in US$)
Table 7: Generic Drug Manufacturing Plant: Raw Material Requirements
Table 8: Generic Drug Manufacturing Plant: Costs Related to Salaries and Wages (in US$)
Table 9: Generic Drug Manufacturing Plant: Costs Related to Other Capital Investments (in US$)
Table 10: Details of Financial Assistance Offered by Financial Institutions
Table 11: Generic Drug Manufacturing Plant: Capital Costs (in US$)
Table 12: Generic Drug Manufacturing Plant: Techno-Economic Parameters
Table 13: Generic Drug Manufacturing Plant: Taxation and Depreciation
Table 14: Generic Drug Manufacturing Plant: Income Projections (in US$)
Table 15: Generic Drug Manufacturing Plant: Expenditure Projections (in US$)
Table 16: Generic Drug Manufacturing Plant: Cash Flow Analysis Without Considering the Income Tax Liability
Table 17: Generic Drug Manufacturing Plant: Cash Flow Analysis on Considering the Income Tax Liability
Table 18: Generic Drug Manufacturing Plant: Profit and Loss Account


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.